Results 201 to 210 of about 87,373 (338)

Interleukin-6 Inhibits Fas-Induced Apoptosis and Stress-Activated Protein Kinase Activation in Multiple Myeloma Cells [PDF]

, 1997
Dharminder Chauhan, Surender Kharbanda, Atsushi Ogata, Mitsuyoshi Urashima, Gerrard Teoh, Michael J. Robertson, Donald Küfe, Kenneth C. Anderson   +7 more
openalex   +1 more source

The Role of Histone Methyltransferase SETDB1 in Normal and Malignant Hematopoiesis

Cancer Science, EarlyView.
In this review, we discuss the role of SETDB1 in gene regulation, including an overview of its structural features and key cofactors. We also highlight the lineage‐specific roles of SETDB1 in both normal hematopoietic processes and hematological malignancies, emphasizing its function as an immune checkpoint molecule that suppresses natural killer cell ...
Yu‐Hsuan Chang, Susumu Goyama
wiley   +1 more source

Cholesterol metabolism reprogramming in multiple myeloma: examining its specificity and impact on the immune microenvironment. [PDF]

Am J Cancer Res
Teng H, Wang F, Liu H, Zhang X.
europepmc   +1 more source

A novel mature B‐cell line (DOBIL‐6) producing both parathyroid hormone‐related protein and interleukin‐6 from a myeloma patient presenting with hypercalcaemia [PDF]

, 1998
Minoru Ohmori, Masami Nagai, Mitsuhiro Fujita, Hiroaki Dobashi, Taizo Tasaka, Genji Yamaoka, Koichi Kawanishi, Masafumi Taniwaki, Jiro Takahara   +8 more
openalex   +1 more source

Organoids in Haematologic Research: Advances and Future Directions

Cell Proliferation, EarlyView.
This review focuses on the advancements in organoid technology and its transformative role in haematological research, particularly in the modelling of haematopoietic tissues, blood diseases and drug development. It also offers an outlook on the future prospects of organoids in personalised medicine and the study of disease mechanisms.
Liangzheng Chang, Lu Li, Yuling Han, Hui Cheng, Liuliu Yang   +4 more
wiley   +1 more source

A thematic analysis of prognostic, diagnostic, and therapeutic of circulating miRNA biomarkers in bortezomib-resistant multiple myeloma. [PDF]

SAGE Open Med
Bamfield-Cummings S, Silva J, Karim ZA.
europepmc   +1 more source

Significance of parathyroid hormone-related protein as a factor stimulating bone resorption and causing hypercalcemia in myeloma [PDF]

, 1998
Hideki Tsujimura, Fumitaka Nagamura, Tohru Iseki, Shoichiro Kanazawa, Hiromitsu Saisho   +4 more
openalex   +1 more source

Phase I study of pomalidomide in relapsed or refractory Waldenström macroglobulinaemia

British Journal of Haematology, EarlyView.
Karan L. Chohan, Donna M. Weber, Lei Feng, L. Michael Wang, Sattva S. Neelapu, Jasper Olsem, Ralph J. Johnson, Claudia Morales de Partovi, Robert Z. Orlowski, Sheeba K. Thomas   +9 more
wiley   +1 more source

Super‐Enhancer Target Gene CBP/p300‐Interacting Transactivator With Glu/Asp‐Rich C‐Terminal Domain, 2 Cooperates With Transcription Factor Forkhead Box J3 to Inhibit Pulmonary Vascular Remodeling

Cell Proliferation, EarlyView.
During hypoxia, the transcriptional effect of super‐enhancer in promoting CBP/p300‐interacting transactivator with Glu/Asp‐rich C‐terminal domain, 2 reduced, eventually leading to the thickening of the smooth muscle layer of the pulmonary artery.
Songyue Li, Jingya Zhang, Xu Wang, Xinru Wang, Yuyu Song, Xinyue Song, Xiuli Wang, Weiwei Cao, Chong Zhao, Jing Qi, Xiaodong Zheng, Yan Xing   +11 more
wiley   +1 more source

Selinexor's Immunomodulatory Impact in Advancing Multiple Myeloma Treatment. [PDF]

Cells
Tasbihi K, Bruns H.
europepmc   +1 more source